| 항목 | 값 |
|---|---|
| DrugBank ID | DB06595 |
| 근거 수준 | L5 (컴퓨터 예측) |
| 예측 적응증 수 | 21 |
다음은 TxGNN 모델에 의해 예측된 잠재적 신규 적응증입니다. 점수가 높을수록 관련성이 높습니다.
| # | 적응증 | 출처 |
|---|---|---|
| 1 | obsolete classic mast cell leukemia | TxGNN Knowledge Graph |
| 2 | acute myeloblastic leukemia with maturation | TxGNN Knowledge Graph |
| 3 | acute myeloid leukemia with NPM1 somatic mutations | TxGNN Knowledge Graph |
| 4 | acute myeloblastic leukemia without maturation | TxGNN Knowledge Graph |
| 5 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | TxGNN Knowledge Graph |
| 6 | therapy related acute myeloid leukemia and myelodysplastic syndrome | TxGNN Knowledge Graph |
| 7 | mast cell leukemia | TxGNN Knowledge Graph |
| 8 | inherited acute myeloid leukemia | TxGNN Knowledge Graph |
| 9 | aleukemic mast cell leukemia | TxGNN Knowledge Graph |
| 10 | mastocytosis | TxGNN Knowledge Graph |
| 11 | acute myeloid leukemia with CEBPA somatic mutations | TxGNN Knowledge Graph |
| 12 | acute myeloid leukemia with minimal differentiation | TxGNN Knowledge Graph |
| 13 | acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | TxGNN Knowledge Graph |
| 14 | systemic mastocytosis | TxGNN Knowledge Graph |
| 15 | myeloid leukemia | TxGNN Knowledge Graph |
| 16 | acute myeloid leukemia with t(6;9)(p23;q34) | TxGNN Knowledge Graph |
| 17 | acute myeloid leukemia with t(8;16)(p11;p13) translocation | TxGNN Knowledge Graph |
| 18 | acute myeloid leukemia with t(9;11)(p22;q23) | TxGNN Knowledge Graph |
| 19 | aggressive systemic mastocytosis | TxGNN Knowledge Graph |
| 20 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | TxGNN Knowledge Graph |
| 21 | unclassified acute myeloid leukemia | TxGNN Knowledge Graph |
이 예측은 연구 목적으로만 사용되며 의료 조언을 구성하지 않습니다. 임상 적용 전에 반드시 적절한 검증이 필요합니다.